Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.69T
24h Vol:
$10.68B
Dominance:
MSFT:4.75%
Stocklytics Platform
Asset logo  MLAB
Mesa Laboratories
MLAB
60 / 100
$122.22arrow_drop_up1.33%$1.61

Performance History

Stocklytics logo
Key Stats
Open$118.81
Prev. Close$118.60
EPS0.17
Dividend$0.64
Next Earnings DateSep 13, 2024
Dividend Yield %0.54%
Market Cap$627.65M
PE Ratio709.47
LOWHIGH
Day Range117.53
120.63
52 Week Range82.86
162.83
Ratios
P/B Ratio1.41
Revenue$219.08M
Operating M. %2.09%
Earnings$930.00K
Earnings Growth %-50.29%
EBITDA Margin %16.32%
ROE %0.24%
EPS0.17

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$420.98
24H (%)arrow_drop_down0.49%
24H ($)-$2.09
MARKET CAP$3.08T
PRICE$189.84
24H (%)arrow_drop_up0.06%
24H ($)$0.12
MARKET CAP$2.80T
PRICE$943.59
24H (%)arrow_drop_down0.28%
24H ($)-$2.70
MARKET CAP$2.24T
PRICE$1,412.13
24H (%)arrow_drop_down1.67%
24H ($)-$24.04
MARKET CAP$617.64B

About Mesa Laboratories (MLAB)

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Sector
Technology
Industry
Scientific & Technical Instruments
CEO
Mr. Gary M. Owens
Headquarters
Lakewood
Employees
698
Exchange
NASDAQ
add Mesa Laboratories  to watchlist

Keep an eye on Mesa Laboratories

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Mesa Laboratories 's (MLAB) price per share?

The current price per share for Mesa Laboratories (MLAB) is $120.61. The stock has seen a price change of $2.01 recently, indicating a 1.69% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Mesa Laboratories (MLAB)?

For Mesa Laboratories (MLAB), the 52-week high is $162.83, which is 35.01% from the current price. The 52-week low is $82.86, the current price is 45.56% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Mesa Laboratories (MLAB) a growth stock?

Mesa Laboratories (MLAB) has shown an average price growth of 0.41% over the past three years. It has received a score of 22 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Mesa Laboratories as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Mesa Laboratories (MLAB) stock price performance year to date (YTD)?

As of the latest data, Mesa Laboratories (MLAB) has a year-to-date price change of 13.5%. Over the past month, the stock has experienced a price change of 17.67%. Over the last three months, the change has been 17.43%. Over the past six months, the figure is 31.64%. Looking at a longer horizon, the five-year price change stands at -52.55%.

help
Is Mesa Laboratories (MLAB) a profitable company?

Mesa Laboratories (MLAB) has a net income of $930K, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 61.02% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 2.09% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $219.08M, with a revenue growth rate of 18.85%, providing insight into the company's sales performance and growth. The gross profit is $133.69M. Operating income is noted at -$30.5M. Furthermore, the EBITDA is $38.93M.

help
What is the market capitalization of Mesa Laboratories (MLAB)?

Mesa Laboratories (MLAB) has a market capitalization of $627.65M. The average daily trading volume is 25.6K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level